| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.91B | 78.91B | 75.93B | 74.88B | 71.98B | 62.27B |
| Gross Profit | 30.40B | 30.40B | 29.82B | 29.12B | 25.85B | 22.74B |
| EBITDA | 15.86B | 15.86B | 16.17B | 16.04B | 11.40B | 11.21B |
| Net Income | 9.62B | 9.62B | 8.30B | 7.95B | 3.72B | 6.16B |
Balance Sheet | ||||||
| Total Assets | 166.20B | 166.20B | 147.81B | 145.07B | 151.50B | 139.61B |
| Cash, Cash Equivalents and Short-Term Investments | 16.69B | 16.69B | 11.46B | 11.13B | 12.99B | 12.05B |
| Total Debt | 56.01B | 56.01B | 47.92B | 46.60B | 50.64B | 48.70B |
| Total Liabilities | 97.83B | 97.83B | 91.58B | 92.01B | 96.70B | 90.33B |
| Stockholders Equity | 62.24B | 62.24B | 51.26B | 47.79B | 48.90B | 44.37B |
Cash Flow | ||||||
| Free Cash Flow | 10.81B | 10.81B | 9.58B | 10.02B | 8.16B | 8.27B |
| Operating Cash Flow | 13.26B | 13.26B | 11.66B | 12.24B | 10.24B | 10.00B |
| Investing Cash Flow | -11.31B | -11.31B | -3.28B | -3.18B | -2.49B | -15.49B |
| Financing Cash Flow | 3.64B | 3.64B | -8.88B | -8.73B | -7.50B | 785.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $111.66B | 31.52 | 27.30% | 0.79% | 0.22% | 26.66% | |
78 Outperform | $212.92B | 20.10 | 12.79% | 1.95% | 4.27% | 17.72% | |
76 Outperform | $78.41B | 34.49 | 10.91% | 1.56% | 2.97% | 18.14% | |
75 Outperform | $128.94B | 33.20 | 20.69% | 1.25% | 8.24% | 6.21% | |
71 Outperform | $74.67B | 24.98 | 91.71% | 2.37% | -0.41% | -10.88% | |
71 Outperform | $46.37B | 53.88 | 24.24% | 1.31% | 0.98% | -7.51% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |